Microsoft Word - S_2019_GRC-02_025_S43 Share Acquisition_EN Page 1 – Translation – GRC-02/2019/025 11 December 2019 Subject: Report of the Asset Acquisition To: President The Stock Exchange of
Ref. WINNER 0009/20108 Page 1 of 10 Disclosures on the asset acquisition of Winner Group Enterprise Public Company Limited on share purchase of Aesthetic Zecret (At-Ze) Company Limited (Schedule 1
company will sign the share purchase agreement after receiving approval from the Extraordinary General Meeting of Shareholders by 15th August 2020 and is expected to be able to pay and transfer the shares
transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging
into the sign of Share Sale and Purchase Agreement, including transfer of related brand names from the selling shareholder(s). According to the Notification of the Capital Market Supervisory Board No
2.04 -13.23% 2.15 2.27 -4.99% Finance costs (32.49) (34.40) -5.55% (62.48) (66.64) -6.24% Share of profit of investment in associate 0.61 0.81 -23.85% 1.50 1.47 1.63% Tax expense (75.16) (64.61) 16.34
responsibilities, from BGP Spectrum, currently available and to be available in the future, as of the date of entire business transfer, including 8,100,000 ordinary shares at the par value of Baht 10 per share in
system of new medicines according to the additional standards SET forth by the Food and Drug administration. Therefore, it is necessary to use the capital to proceed the project amount 32,000,000 baht
% % Selling Expenses to Sales 15.7% 14.3% 15.3% 13.8% Administrative Expenses 151 122 +24% 277 260 +7% % Administrative Expenses to Sales 11.4% 8.9% 10.3% 9.0% Finance Costs 15 5 +190% 27 11 +153% Share of